2016-2020 UK Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
![](/report_cover/2215/2016-2020-uk-cancer-diagnostics-market-segmentation-analysis-hospitals-commercial-labs-oncogenes_en.gif)
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. “2016 UK Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains” is VPGMarketResearch’s new study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
I. INTRODUCTION
II. WORLDWIDE MARKET OVERVIEW
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers
2. Oncogenes
3. Polypeptide Growth Factors
4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
IX. COMPETITIVE PROFILES
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
X. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
II. WORLDWIDE MARKET OVERVIEW
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers
2. Oncogenes
3. Polypeptide Growth Factors
4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
IX. COMPETITIVE PROFILES
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
X. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
LIST OF TABLES
Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: U.K., Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
U.K., Estimated Cancer Death Rates
U.K., Laboratories Performing Cancer Diagnostic Tests by Market Segment
U.K., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
U.K., Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
U.K., All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
U.K., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts By Test
U.K., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
U.K., Total Cancer Diagnostic Sales Forecasts by Market Segment
U.K., All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
U.K., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.K., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.K., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Total Cancer Diagnostics Sales and Market Shares Forecasts
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier
Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: U.K., Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
U.K., Estimated Cancer Death Rates
U.K., Laboratories Performing Cancer Diagnostic Tests by Market Segment
U.K., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
U.K., Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
U.K., All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
U.K., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts By Test
U.K., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
U.K., Total Cancer Diagnostic Sales Forecasts by Market Segment
U.K., All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
U.K., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.K., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.K., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Total Cancer Diagnostics Sales and Market Shares Forecasts
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier